Baader Bank Aktiengesellschaft’s Gilead Sciences GILD Stock Holding History

Baader Bank Aktiengesellschaft’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.09M	Buy	8,320 +1,327	+19%	+$186K	0.09%	166
2025 Q4	$844K	Sell	6,993 -3,790	-35%	-$461K	0.06%	205
2025 Q3	$1.17M	Sell	10,783 -884	-8%	-$100K	0.08%	163
2025 Q2	$1.25M	Sell	11,667 -1,451	-11%	-$154K	0.09%	165
2025 Q1	$1.45M	Buy	13,118 +2,274	+21%	+$235K	0.11%	139
2024 Q4	$1M	Buy	10,844 +7,328	+208%	+$660K	0.07%	167
2024 Q3	$287K	Sell	3,516 -4,736	-57%	-$361K	0.02%	301
2024 Q2	$566K	Buy	+8,252	New	+$551K	0.04%	242
2022 Q4	–	Sell	-8,894	Closed	-$549K	–	388
2022 Q3	$549K	Buy	8,894 +4,610	+108%	+$291K	0.04%	258
2022 Q2	$265K	Sell	4,284 -124,476	-97%	-$7.71M	0.02%	289
2022 Q1	$7.66M	Hold	128,760	–	–	0.61%	42
2021 Q4	$9.35M	Buy	+128,760	New	+$8.87M	0.72%	33

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Baader Bank Aktiengesellschaft's GILD Position: Q1 2026 in Review

Baader Bank Aktiengesellschaft increased its Gilead Sciences (GILD) stake by 19% in Q1 2026, buying an estimated $186K and bringing the position to 8,320 shares worth $1.09M. The position accounts for 0.09% of the portfolio, ranked #166.

Baader Bank Aktiengesellschaft first reported a position in GILD in Q4 2021 and has held it in 12 quarters since. The position peaked at $9.35M in Q4 2021. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

Baader Bank Aktiengesellschaft held 8,320 shares of Gilead Sciences worth $1.09M as of Q1 2026.
Baader Bank Aktiengesellschaft bought 1,327 Gilead Sciences shares in Q1 2026, an estimated $186K.
Gilead Sciences made up 0.09% of Baader Bank Aktiengesellschaft's portfolio in Q1 2026, its #166 holding.
Baader Bank Aktiengesellschaft first reported a position in Gilead Sciences in Q4 2021 and has held it in 12 quarters since.
Baader Bank Aktiengesellschaft's Gilead Sciences position peaked at $9.35M in Q4 2021.
2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Baader Bank Aktiengesellschaft's 13F filing for Q1 2026, filed 8 May 2026.